INTRODUCTION
Dystonia is a movement disorder characterized by sustained muscle contractions, frequently causing twisting and repetitive movements or abnormal postures . Over 12 different gene loci have been implicated in various forms of primary, hereditary dystonia (Mueller et al., 1998; Klein et al., in press, b) . The TOR1A (DYT1) locus on human chromosome 9q34 is responsible for the most severe form of hereditary dystonia-early onset, generalized torsion dystonia (Ozelius et al., 1989; Kramer et al., 1994) . In this form, symptoms usually begin in a limb at a mean age of 12.5 years, with progression, in most cases, to involve multiple body parts over a subsequent 5-year period . Inheritance follows an autosomal dominant mode of transmission with reduced penetrance (30 -40%; Risch et al., 1990) . The TOR1A gene on human chromosome 9q34 (Ozelius et al., 1989) was identified and determined to encode a novel protein, torsin A (Ozelius et al., 1997b) . A single mutation, a 3-bp (GAG) deletion, in the heterozygous state accounts for 50 -60% of non-Jewish (NJ) individuals and over 90% of Ashkenazi Jewish (AJ) individuals with this form of dystonia Klein et al., in press, a) . The predominance of this mutation may reflect both a unique phenotype produced by the altered protein, with loss of one of a pair of glutamic acids in the carboxy-terminal region, and an increased frequency of this mutation, due to genetic instability in an imperfect tandem 24-bp repeat in the region of the deletion (Klein et al., 1998) .
The TOR1A gene is expressed selectively in specific regions of the human brain, with highest levels in the dopaminergic neurons of the substantia nigra (Augood et al., 1998 (Augood et al., , 1999 . The involvement of these neurons in the etiology of dystonia is consistent with other genetic, pharmacologic, and clinical studies. Metabolic deficiency states that compromise dopamine synthesis can also manifest with severe childhood-onset dystonia, including mutations in genes for GTP-cyclohydrolase I (Ichinose et al., 1994) and tyrosine hydroxylase Knappskog et al., 1995; Wevers et al., 1999) underlying dopa-responsive dystonia and in genes for L-aromatic amino acid decarboxylase and dihydropteridine reductase (Blau et al., 1998) in other neurologic syndromes with marked dystonic features. Dystonic symptoms can also be elicited by D2 receptor blockers (LeWitt, 1995) , and a missense mutation in the D2 receptor has been implicated in a family with myoclonus dystonia (Klein et al., 1999) .
The TOR1A gene encoding torsin A is a member of a larger gene family, including an adjacent gene, TOR1B (DQ1), which encodes a highly homologous (70%) protein, torsin B. The human genome contains at least two other related genes, TOR2A and TOR3A (TORP1 and TORP2; Ozelius et al., 1997b) . All four human genes are expressed in most fetal and adult tissues. The interest in the TOR1A gene family derives not only from its role in a neurologic disease, but also from the similarity of the deduced protein, torsin A, to a superfamily of proteins with a variety of chaperone-like functions . The similarity includes an ATP-binding domain and 11 conserved motifs and predicted secondary structure Ozelius et al., 1997b; Lupas et al., 1997) shared with the heat shock protein (HSP)/Clp ATPase and the "ATPase associated with a variety of cellular activities" (AAA) superfamily (Parsell and Lindquist, 1993; Gottesman et al., 1997; Confalonieri and Duguet, 1995) . This AAAϩ family includes the N-ethylmaleimide-sensitive fusion (NSF) protein, which has been implicated in vesicle fusion and neurotransmitter release (Hanson et al., 1997; Haas, 1998) , and HSP104, which has been shown to determine the state of prion aggregation (DebBurman et al., 1997) .
This study documents the exon structure and physical map of the human TOR1A and TOR1B genes. These genes were screened for mutations using intronic and flanking primers to amplify and scan genomic DNA from three types of dystonia patients: those with early onset, generalized dystonia who lack the GAG-deletion; those who appear to be homozygous in this 9q34 chromosomal region; and a representative AJ individual with late onset dystonia, who shared a common haplotype of polymorphic alleles in this region with other late onset AJ individuals, suggesting a founder mutation. This study also elucidates the extended TOR1A gene family in a variety of species and clarifies its relationship to the AAAϩ family.
MATERIALS AND METHODS
Clinical criteria and patient samples. Clinical criteria and patient samples from affected individuals were obtained through the Movement Disorders Groups at Columbia Presbyterian Medical Center, Mount Sinai School of Medicine, and Beth Israel Hospital (New York) under IRB-approved, informed consent protocols. The criteria for the diagnosis of primary torsion dystonia and the methods of evaluation were the same as described previously .
Analysis of gene structure. DNA was processed according to standard methods (Sambrook et al., 1989) . Cosmids spanning the TOR1A region (Ozelius et al., 1997a) were sequenced directly using primers spaced throughout the cDNAs (DQ1 and DQ2; Ozelius et al., 1997b) . The resultant genomic sequence was aligned with the cDNA sequence revealing the exon-intron boundaries. The size of the introns was determined by amplifying across the introns using exonic primers with Elongase enzyme and 1.8 mM Mg 2ϩ when possible, according to the manufacturer's instructions (Life Technologies). o C for 5 min) was performed after enzymatic clean-up with exonuclease I and shrimp alkaline phosphatase (USB) for 15 min at 37 o C and 15 min at 85 o C. After DNA extraction from whole blood or lymphoblastoid lines following standard protocols, PCR amplification was performed using primers 6418 and 6419 spanning the critical region of the TOR1A gene (Ozelius et al., 1997b) . PCR products were resolved on a denaturing 6% polyacrylamide gel and visualized by silver staining (Deimling et al., 1993; Klein et al., in press, a) .
Dideoxy
Database analysis. The amino acid sequences of torsin A and torsin B were used to search the database of expressed sequence tags (dbEST) to identify additional homologues and orthologues. ESTs were grouped by nucleotide sequence and used to search dbEST iteratively. In seven cases, UniGene clusters that represent homologues were identified. ESTs were assembled into contigs with Sequencher (GeneCodes) or with the EST Assembly Machine and EST Extractor at TIGEM (http://gcg.tigem.it/cgi-bin/uniestass.pl; http:// gcg.tigem.it/blastextract/estextract.html). Amino acid sequences of EST contigs were predicted from open reading frames with similarity to torsin A and torsin B. The Caenorhabditis elegans database (http://www.sanger.ac.uk/Projects/C_elegans/blast_server.shtml) was searched to identify predicted proteins from the C. elegans genome project. Gene designations were approved by the Human and Mouse Naming Committees.
Phylogenetic relationships were determined by alignment of the predicted amino acid sequences of torsins, torps, and heat-shock proteins using ClustalX (Thompson et al., 1994) . The tree was calculated by ClustalX with 1000 bootstrap trials, excluding positions with gaps and correcting for multiple substitutions, and was displayed for plotting with TreeView 1.5 (http://taxonomy.zoology. gla.ac.uk/rod/rod.html).
Secondary structure predictions were made using the Protein Sequence Analysis Server at Boston University (http://bmerc-www. bu.edu/psa/).
RESULTS

Exon Structure of TOR1A and TOR1B
Human TOR1A and TOR1B transcripts (DYT1 or DQ2, and DQ1, respectively) were found previously to be highly similar (71% identical at the amino acid level) and encoded by adjacent genes on chromosome 9q34, which face in opposite orientations with their 3Ј ends as nearest neighbors (Ozelius et al., 1997a,b) . Each gene has five exons spanning about 10 kb, with the same location of splice sites; these two genes are separated from each other in the genome by about 2 kb (Fig. 1) . The size of the exons and introns of these genes and the nucleotide sequences near the intron-exon junctions are listed in Table 1 .
Screen for Mutations in Dystonic Individuals
Based on the hypothesis that other mutations, in addition to the GAG deletion, occur in the TOR1A gene and that at least some of these may cause dystonia, a mutational screen of coding sequences was undertaken for TOR1A and TOR1B for three groups of dystonia patients (total 23). All affected individuals tested negative for the GAG deletion. The first group consisted of 17 patients (5 of AJ descent and 12 non-Jewish) with features typical of early onset dystonia, including limb onset from 3 to 19 years of age with spread to involve at least one and frequently multiple body parts ( Table 2 ). The second group comprised 5 patients (4 AJ and 1 AJ/NJ) with early to midlife onset (4 to 35 years) whose haplotype in the TOR1A region appeared homozygous. This homozygosity could have resulted from consanguinity or deletion of genomic DNA in this region on one chromosome, for some or all of the polymorphic markers-D9S2160, D9S2161, D9S63, D9S2162, in a Յ320-kb region, including the TOR1A locus (Ozelius et al., 1997a ; Table 3 ). The third group was represented by one individual from a set of 11, out of 88 AJ patients tested with late onset, focal dystonia, who carried the same haplotype for nine polymorphic markers (D9S62a, D9S62b, D9S159, D9S2158, D9S2159, D9S2160, D9S63, D9S2162, and ASS), which span the TOR1A region. Age of onset in these 11 patients ranged from 29 to 66 years (mean age 48 years) with focal symptoms involving neck (3), larynx (2), upper face (4), or arm (2). Phasing of these chromosomes was possible in one family with two affected individuals confirmed with a common haplotype.
Genomic DNA from these 23 patients was used to amplify exons from TOR1A and TOR1B with the flank- The restriction map of this genomic region: restriction enzymes, X, XbaI; E, EcoRI; N, NotI; and fragment sites (Ozelius et al., 1997a) . 
Sizes of introns were approximated by gel resolution of PCR products.
ing intronic primers listed in Table 4 . A screen of known coding sequence in the five exons of TOR1A (excluding the 40 bp of the coding region and the 5Ј splice junction of exon 1, as this region is very G-C-rich and proved difficult to amplify consistently) and exons 2-5 of TOR1B (again the region around the 5Ј end of intron 1 was difficult to PCR) did not reveal any new changes that would alter the amino acid sequence of the protein or splicing of the messages. A number of previously described polymorphisms were observed (Ozelius et al., 1997a) . None of the five apparently homozygous patients was heterozygous at any of three polymorphisms in the TOR1A gene (Ozelius et al., 1997b) , leaving open potential homozygosity or hemizygosity due to a chromosomal deletion.
A Gene Family of Torsins and Torsin-Related Proteins in Different Species
We used the sequences of torsin A and torsin B to search databases for orthologues and homologues in other species. Mouse orthologues of both genes are represented by ESTs, which are clustered in the UniGene database. Pig and rat orthologues for torsin A are also present in the EST database. We also identified homologues in mammals, fish, flies, and nematodes (see Table 5 ). A phylogenetic analysis of the predicted protein sequences (Fig. 2) indicated that one of these-an EST from zebrafish-is closely related to torsin A and torsin B, but not sufficiently similar to represent an orthologue and so is termed torsin C. Other homologues are more distant from the torsins and so are termed torsin-related proteins, or torps. b Three of these individuals had all known AJ ancestors; one was 7/8 AJ, and one was 1/2 AJ. a Markers listed from centromere to telomere: D9S2160 -Ͻ40 kb-D9S2161-150 kb-D9S63-130 kb-D9S2162 (Ozelius et al., 1997a) .
b Position of TOR1A gene. c Not tested. d This individual had onset at 7 years in the arm with eventual involvement of the arm and neck and a positive family history of movement disorder (father with tremor). He was also apparently homozygous for markers D9S159 -D9S2158 -D9S2159, which are proximal to DS2160 (total region of 100 kb). a PCR products were generated using oligonucleotides synthesized from intronic sequences, and accordingly the size of each product includes both intron and exon sequence.
b Not done. It was not possible to identify primers that could consistently PCR this exon.
Torp2 and torp3 are expressed by both mouse and human. Human ESTs for both torp2 and torp3 and mouse ESTs for torp2 are clustered in the UniGene database, which facilitated assembly of cDNA sequence (see Table 5 ). Torp4 is expressed by Drosophila melanogaster, but apparently not by other species. The three torps expressed by C. elegans are more related to one another than to other members of the family and so together are denoted torp5, with subtypes a, b, and c. Since the C. elegans genome project is largely complete, there are probably not additional members in nematodes. An apparent pseudogene for TOR1B is located on human chromosome 2p13 with several BAC clones from this region showing highly homologous sequences; however, there is no open reading frame of any length among these sequences.
We included in the phylogenetic analysis some members of the HSP101 superfamily of heat-shock proteins, representing both class 1 and class 2 subtypes (Parsell and Lindquist, 1993) . These clearly group together, but far from the torsins and torps. Thus the Torsin family of proteins is not simply a branch of the HSP101 family, but is a separate group that shares some characteristic domains (Ozelius et al., 1997b) .
DISCUSSION
The TOR1A (DYT1) gene for early onset torsion dystonia is remarkable in two ways: the large majority of patients with this syndrome bear the same mutation (GAG deletion) in the heterozygous state (Ozelius et al., 1997b; Klein et al., in press, a) , and identification of this gene reveals a novel family of proteins with features of the heat-shock/chaperone and AAAϩ superfamily (Ozelius et al., 1997b; Neuwald et al., 1999) . The present study defines the exon structure of this gene and its adjacent homologue, TOR1B. A screen for additional mutations in the TOR1A and the TOR1B loci in several types of dystonia patients with features consistent with TOR1A involvement did not reveal additional mutations. The inability to identify additional mutations in the TOR1A gene suggests that the struc- Note. Proteins are named torsins or torps according to phylogenetic relationships as determined by ClustalX and shown in Fig. 2 . Species are denoted for orthologs as follows: h, Homo sapiens; m, Mus musculus; r, Rattus norvegicus; dr, Danio rerio; dm, Drosophila melanogaster; ce, Caenorhabditis elegans. Gene names have been approved by the Mouse and Human Gene Nomenclature Committees. Accession numbers indicate either a GenBank entry for a cloned gene or a representative EST.
FIG. 2.
Phylogenetic relationships among the Torsin family and relationship to the HSP101 family. For each protein, the orthologue for which there was the longest sequence was used for the phylogeny analysis. Orthologues, when included, are represented by much shorter branches than those separating homologues (not shown). Branches marked by dots are not statistically significant. tural change in the torsin A protein caused by the GAG deletion (loss of a glutamic acid residue in the carboxy terminal) may be functionally unique. While a phylogenetic analysis of the TOR1A gene family showed it to represent a distinct branch related to the AAAϩ (HSP/ Clp-ATPase-AAA) superfamily, a detailed sequence comparison between the torsin family members and this superfamily has revealed shared functional and configurational domains (Ozelius et al., 1997b; Neuwald et al., 1999) . This superfamily is typified by hexameric architecture, protein-protein interactions, and conformational changes mediated by ATP hydrolysis, and its members mediate a wide range of cellular functions. The function of torsin A remains to be determined, but the high conservation of this family among species suggests an important role in cell biology.
Dominantly inherited conditions, such as early onset dystonia, can result from mutant forms of a protein that either act in a "gain of function" manner unrelated to the functions of the normal protein counterpart, e.g., in triplet repeat diseases where extended glutamine residues cause intracellular precipitation of proteins (Paulson and Fishbeck, 1996; Ross, 1997; DiFiglia et al., 1997) , or in a "dominant negative" manner, blocking normal functions of oligomeric protein complexes, such that even a minority of mutant subunits in the complex can disrupt its function, e.g., a missense mutation in one subunit of a K ϩ channel that causes deafness (Kubisch et al., 1999) . This latter mechanism seems intriguing for dystonia, as members of the AAAϩ family typically form six-member, homo-oligomeric ring structures, which interact with one or more other proteins, frequently with substrate proteins or nucleic acids "threaded" through the hole in the ring. The recently described crystal structure of NSF (Lenzen et al., 1998; Neuwald, 1999; Yu et al., 1998 )-a member of the AAAϩ family involved in vesicle fusion (Whiteheart et al., 1994) -and alignment of torsin A with its structural domains suggest that the region of the GAG deletion in torsin A may be involved either in the formation of the ring structure or in the interaction with partner proteins (D. Corey, unpublished observations). Mutations in the carboxy-terminal portion of some of the HSP proteins, e.g., HS1U and filamentation temperature-sensitive protein, can block association with the partner proteins in a dominant manner, thereby inhibiting proteolytic function of the complex (Missiakas et al, 1996; Akiyama et al, 1994) . By analogy, the GAG deletion in the carboxy region of torsin A could prevent function of an oligomeric complex, even if only a few subunits of a heteromeric torsin A ring bear the mutation. Thus, in the heterozygous condition, with expression of normal and mutant (GAG-deleted) forms of torsin A, the function of the complex might be compromised. Other mutations in torsin A present in the heterozygous state might not disrupt function to the same extent and thus might lead to a milder or no phenotype. However, disruptive mutations present in both alleles of torsin A might cause dystonia or another type of disease.
Based on the above hypotheses, three possible outcomes of other mutations in TOR1A were considered. First, any mutation that disrupts the function of the oligomeric complex might lead to a syndrome of dominantly inherited, early onset dystonia. Presumably only a limited number of changes in the structure of torsin A could produce a dominant-negative effect, and some of these might be present in those early onset, generalized dystonia patients who do not bear the GAG deletion. To test this possibility, we selected a set of AJ and NJ patients without the GAG deletion who had early onset dystonia (Ͻ19 years) that began in a limb and progressed to involve at least one other body part (not excluding cranial involvement). Second, if disruption of torsin A function causes dystonia, then null mutations in both alleles of the TOR1A gene might also produce a dystonic syndrome. In the course of haplotype analysis in dystonia cases, a number of individuals were identified who were apparently homozygous for alleles in and around the TOR1A locus and thus might bear a disruptive mutation in one TOR1A allele and deletion of the other allele. Third, some cases of late onset/focal dystonia might be caused by dominantly acting, but less disruptive mutations in the TOR1A gene. This last hypothesis was supported by the finding that 11/88 AJ patients with late onset dystonia appeared to share a common haplotype in the TOR1A region (Ozelius, 1994) , suggesting a possible founder mutation with a milder phenotype. Sequence analysis of coding regions of TOR1A and TOR1B genes in genomic DNA from these three types of affected individuals, however, revealed no further mutations in TOR1A nor any in TOR1B. It remains possible that mutations in noncoding sequences in the 5Ј flanking region or introns of these genes can disrupt transcription, processing, or stability of these messages or that the GAG deletion confers a novel, deleterious property to torsin A. These patients may also have mutations in one of the 12 or more other human gene loci implicated in primary dystonia (Mueller et al., 1998; Klein et al., in press, b) , including other members of the TOR1A gene family or loci encoding nonhomologous proteins that interact functionally with torsin A. To date, however, all multiplex families with early onset dystonia with linkage to 9q34 have the GAG deletion. Further, some patients manifesting apparent homozygosity in this chromosomal region may be hemizygous for TOR1A and/or TOR1B genes with a consequent haploinsufficiency state.
The present study provides the foundation for further analysis of the torsin A gene family and its role in human disease. The elucidation of gene structure of TOR1A and TOR1B and the description of intronic primers for PCR will allow the search for mutations to continue at the genomic level. The elucidation of a cross-species and multimember gene family should aid in defining other syndromes mediated by this protein family. The features of torsin A shared with the HSP/ Clp-ATPase and AAA superfamily and the implication of compromised dopaminergic function in dystonia provide clues as to the function of this new class of proteins in neurons and a link to other movement disorders.
